SmartHelping acquisition case study
Cold Email SaaS Acquisition Analysis: Is an $8M ARR Business Worth $24M?
The model projects a 58.6% base-case IRR, but only 9.7% in the downside case. Here is how revenue quality, financing, operating costs, and exit assumptions shape the $24 million decision.
The opportunity at a glance
This cold-email infrastructure SaaS was founded in 2024 and listed at $24 million, above my usual $10 million screening range. Its combination of growth, profitability, and a broad subscriber base caught my attention.
The business supplies infrastructure used for outbound sales and marketing. That makes recurring usage, service reliability, and customer retention central to the acquisition thesis.
- Asking price
- $24M Reported listing price
- Reported ARR
- $8M Definition requires confirmation
- Reported MRR
- $660K $7.92M when multiplied by 12
- Active subscribers
- 3,100 Reported subscriber count
- Price / reported ARR
- 3.0x $24M divided by $8M
- Monthly revenue / subscriber
- ~$213 $660K divided by 3,100
Listing figures are seller-reported; calculated ratios are screening metrics. Monthly revenue per subscriber assumes MRR and subscriber count cover the same period and population.
Modeling update · September 28, 2026
Update: fixed-cost % and debt %
In this follow-up to the cold email SaaS deal review, I explain using the proper fixed-cost percentage and entering the debt percentage in the financing input. The debt % represents the portion financed with debt, not the buyer's down-payment percentage.
Watch the complete deal review
01 / Revenue quality
Is $8 million ARR or actual annual revenue?
ARR expresses an annualized recurring-revenue run rate at a point in time. Trailing twelve-month revenue measures revenue earned over the preceding year. In a rapidly growing business, those figures can differ substantially.
The stated $660,000 MRR annualizes to $7.92 million, close to the reported $8 million ARR. Neither establishes that the business earned $8 million over the preceding year.
The workbook uses a reconstructed starting point of approximately $7.91 million: it compounds roughly $1 million at 9% monthly for two years. This is a screening assumption, not verified historical revenue. Monthly billing, recognized revenue, cash collections, and the actual growth period need reconciliation before relying on it.
02 / Earnings quality
The 40% versus 50% margin question matters
The listing described approximately 50% EBITDA margins. The workbook's reconstructed historical section produces $3.23 million of EBITDA and a 40.8% margin, using an 80% gross margin, $3.1 million of operating expenses, and no accepted add-backs.
That puts the $24 million price at approximately 7.43x modeled starting EBITDA. This is not verified normalized earnings. The seller's margin and the model's result need reconciliation across periods, infrastructure costs, staffing, owner compensation, and adjustments.
The base forecast then assumes a 50% EBITDA margin. That is an explicit forecast assumption, not a resolution of the historical discrepancy.
03 / Customer durability
Low concentration is encouraging. Retention still needs proof.
The reported concentration figures were attractive: no customer exceeded 2% of revenue, and the top ten represented 11%. That reduces dependence on any single account, if the figures reconcile to customer-level records.
Customers can still share exposure to deliverability, provider dependencies, and changing sales economics. Cohort data should establish retention and expansion. The workbook includes a 105% net-revenue-retention input, but the supplied file does not substantiate it with customer-level data. CAC payback, LTV-to-CAC, and gross retention remain diligence questions.
How I interpret the 83.1 score
The workbook calculates 83.1 overall: Financial 81.8, Quality 85.8, and Risk / Downside 82.0. It is conditional on the inputs and scoring treatment, not a probability of success. Higher risk scores indicate greater modeled protection.
Several retention, acquisition-cost, and technical-diligence measures are marked N/A and excluded. The remaining metrics are reweighted. The resulting score should not be read as evidence that those missing areas have been validated.
What supports further investigation
Reported recurring revenue, substantial margins, rapid growth, and low customer concentration create a promising starting point.
What could change the conclusion
Weaker normalized earnings, poor cohort retention, higher replacement costs, or fragile infrastructure dependencies could materially alter the price a buyer can support.
04 / Acquisition financing
The model requires $14.4 million of buyer equity
| Source | Amount | Share | Modeled terms |
|---|---|---|---|
| Senior loan | $7.20M | 30% | 7% interest; 20-year amortization |
| Seller note | $2.40M | 10% | 2% interest; 5-year amortization |
| Buyer equity | $14.40M | 60% | Invested at closing |
| Total funding | $24.00M | 100% | Equals modeled uses |
Both loans use monthly amortizing payments, producing approximately $1.175 million of combined annual debt service. These are modeling assumptions, not committed lending terms. Transaction fees and the opening liquidity reserve are set to zero, so the $14.4 million equity requirement excludes those additional funding needs.
Five-year base and downside forecasts
The base assumes 20% annual ARR growth, 70% gross margin, and operating expenses at 20% of revenue. The downside assumes a 10% first-year decline, followed by 2%, 1%, 1%, and 1% growth. Its EBITDA margin recovers from 30% to 44%.
Both cases equate annual revenue to ending ARR, a simplifying assumption requiring validation. Base capex is 2% of revenue; downside capex is 2.5% for three years, then 2%. Working capital uses 2% of positive revenue increases.
| Metric | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| Revenue / ending ARR | $9.49 | $11.39 | $13.67 | $16.40 | $19.69 |
| EBITDA | $4.75 | $5.70 | $6.84 | $8.20 | $9.84 |
| Cash to equity before exit | $3.35 | $4.26 | $5.34 | $6.64 | $8.21 |
| Modeled DSCR | 3.85x | 4.62x | 5.55x | 6.66x | 7.99x |
| Metric | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| Revenue / ending ARR | $7.12 | $7.26 | $7.34 | $7.41 | $7.48 |
| EBITDA | $2.14 | $2.18 | $2.57 | $2.82 | $3.29 |
| Cash to equity before exit | $0.78 | $0.82 | $1.21 | $1.49 | $1.97 |
| Modeled DSCR | 1.67x | 1.70x | 2.03x | 2.27x | 2.67x |
Cash flows are pre-tax. DSCR divides EBITDA less capex and incremental working capital by combined debt service; it is a screening measure, not a confirmed lender covenant calculation. Cash to equity then deducts debt service and excludes sale proceeds.
What the equity investor receives in each case
| Metric | Base | Downside |
|---|---|---|
| Initial buyer equity | $14.40M | $14.40M |
| Five-year pre-tax IRR | 58.6% | 9.7% |
| Equity multiple / MOIC | 7.07x | 1.52x |
| Minimum projected DSCR, Years 1–5 | 3.85x | 1.67x |
| Year 5 exit ARR multiple | 4.2x | 3.0x |
| Exit enterprise value | $82.68M | $22.45M |
| Net exit proceeds to equity | $73.99M | $15.56M |
Net sale proceeds deduct 3% selling costs and approximately $6.21 million of remaining debt. IRR and MOIC include the annual equity cash flows plus sale proceeds. The base relies on both operating growth and expansion from roughly 3.03x modeled entry ARR to a 4.2x exit multiple.
The downside maintains projected debt coverage, but its 9.7% pre-tax IRR falls below the workbook's 25% target. Covering debt and earning an adequate equity return are separate tests.
How purchase price and exit multiples change the return
| Purchase price | 1.5x exit ARR | 2.0x exit ARR | 2.5x exit ARR |
|---|---|---|---|
| $16M | 61.0% | 65.5% | 69.4% |
| $20M | 48.2% | 52.8% | 56.9% |
| $24M | 38.7% | 43.4% | 47.6% |
Each cell recalculates financing and equity at the tested price. These results retain base-case growth and margins; they are not the combined operating downside. The main base case uses a 4.2x exit multiple, outside this grid.
The tested $16M–$24M prices are sensitivity inputs, not an independently established offer range. A supportable price still requires verified revenue, sustainable costs, and attainable financing.
My prioritized diligence questions
-
Can revenue be reconciled?
Obtain monthly financials and billing exports. Reconcile ARR, MRR, recognized revenue, collections, refunds, and deferred revenue for matching dates.
-
What explains the margin gap?
Bridge reported profit to normalized EBITDA. Identify owner costs, contractor expenses, infrastructure costs, and each proposed adjustment.
-
Do customers stay profitably?
Review cohorts, gross and net retention, churn reasons, acquisition channels, fully loaded CAC, and gross-profit-based payback.
-
Will the operation transfer successfully?
Review ownership of the technology, vendor arrangements, key-person dependencies, reliability history, and security practices with appropriate specialists.
-
Does the buyer's downside still work?
Test slower growth, margin pressure, higher churn, financing costs, and a lower exit multiple. Establish the required cash cushion before committing.
Apply the same discipline to your deal
Understand the assumptions before committing capital.
Not ready for full underwriting? Talk through the deal with Jason first. A Deal Gut Check is a live discussion; it does not include a workbook or written report.
For a structured review, explore the $1,950 Acquisition Deal Analysis service: an underwriting workbook, downside analysis, scorecard, written findings, and review call. Confirm scope for larger or more complex transactions.
Building your own forecast? Browse my SaaS and recurring-revenue financial models .